EUVIMEDEUVIMED entdecken
Open Access

An alpha 5‐GABA A receptor positive allosteric modulator attenuates social and cognitive deficits without changing dopamine system hyperactivity in rats exposed to valproic acid in utero

Adriana Jesus Souza, Ícaro Silva Freitas iD, Dishary Sharmin, James M Cook, Francisco S Guimarães, Felipe V Gomes iD

Autism Research · 2024

DOI: 10.1002/aur.3178 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Autism Research, 2024. Verfasst von Adriana Jesus Souza und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Ribeirao Preto Medical School, University of São Paulo, Ribeirao Preto, Brazil. Hauptthemen laut MEDLINE: Valproic Acid, Prenatal Exposure Delayed Effects, Receptors, GABA-A, Social Behavior. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Coordination for the Improvement of Higher Education Personnel-Brazil (CAPES)-Finance Code 001, São Paulo Research Foundation, NIMH NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autism spectrum disorders (ASDs) are characterized by core behavioral symptoms in the domains of sociability, language/communication, and repetitive or stereotyped behaviors. Deficits in the prefrontal and hippocampal excitatory/inhibitory balance due to a functional loss of GABAergic interneurons are proposed to underlie these symptoms. Increasing the postsynaptic effects of GABA with compounds that selectively modulate GABAergic receptors could be a potential target for treating ASD symptoms. In addition, deficits in GABAergic interneurons have been linked to dopamine (DA) system dysregulation, and, despite conflicting evidence, abnormalities in the DA system activity may underly some ASD symptoms. Here, we investigated whether the positive allosteric modulator of α5‐containing GABA A receptors (α5‐GABA A Rs) SH‐053‐2′F‐R‐CH3 (10 mg/kg) attenuates behavioral abnormalities in rats exposed to valproic acid (VPA) in utero, an established risk factor for autism. We also evaluated if animals exposed to VPA in utero present changes in the ventral tegmental area (VTA) DA system activity using in vivo electrophysiology and if SH‐053‐2′F‐R‐CH3 could attenuate these changes. SH‐053‐2′F‐R‐CH3 was administered intraperitoneally 30 min before each behavioral test and electrophysiology. In utero VPA exposure caused male and female rats to present increased repetitive behavior (self‐grooming) in early adolescence and deficits in social interaction in adulthood. Male, but not female VPA rats, also presented deficits in recognition memory as adults. SH‐053‐2′F‐R‐CH3 attenuated the impairments in sociability and cognitive function in male VPA‐exposed rats without attenuating the decreased social interaction in females. Adult male and female VPA‐exposed rats also showed an increased VTA DA neuron population activity, which was not changed by SH‐053‐2′F‐R‐CH3. Despite sex differences, our findings indicate that α5‐GABA A Rs positive allosteric modulators may effectively attenuate some core ASD symptoms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Valproic AcidPrenatal Exposure Delayed EffectsReceptors, GABA-ASocial BehaviorAnimalsFemaleRatsMalePregnancyDopamineAutism Spectrum DisorderVentral Tegmental AreaRats, Sprague-DawleyAllosteric RegulationDisease Models, AnimalBehavior, AnimalCognitive Dysfunction

Stichwörter der Autor:innen

GABAA receptorsSH‐053‐2′F‐R‐CH3VPAautismexcitatory‐inhibitory balance

Substanzen

Valproic AcidReceptors, GABA-ADopamineGabra5 protein, rat

Autor:innen und Institutionen

  • Department of Pharmacology, Ribeirao Preto Medical School, University of São Paulo, Ribeirao Preto, Brazil.
  • Department of Chemistry and Biochemistry, Milwaukee Institute of Drug Discovery, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin, USA.

ORCID-Profile: Ícaro Silva Freitas, Felipe V Gomes

Förderung

  • Coordination for the Improvement of Higher Education Personnel-Brazil (CAPES)-Finance Code 001
  • São Paulo Research Foundation
  • NIMH NIH HHS
  • NIH HHS
  • National Council for Scientific and Technological Development-CNPq, Brazil
  • NIDA NIH HHS
  • Fundação de Amparo à Pesquisa do Estado de São Paulo
  • National Institutes of Health

Zitieren

APA

Souza, A. J., Freitas, Í. S., Sharmin, D., Cook, J. M., Guimarães, F. S., & Gomes, F. V. (2024). An alpha 5‐GABA A receptor positive allosteric modulator attenuates social and cognitive deficits without changing dopamine system hyperactivity in rats exposed to valproic acid in utero. Autism Research. https://doi.org/10.1002/aur.3178

Vancouver

Souza AJ, Freitas ÍS, Sharmin D, Cook JM, Guimarães FS, Gomes FV. An alpha 5‐GABA A receptor positive allosteric modulator attenuates social and cognitive deficits without changing dopamine system hyperactivity in rats exposed to valproic acid in utero. Autism Research. 2024. doi:10.1002/aur.3178

BibTeX
@article{Souza2024,
  author = {Souza, Adriana Jesus and Freitas, Ícaro Silva and Sharmin, Dishary and Cook, James M and Guimarães, Francisco S and Gomes, Felipe V},
  title = {An alpha 5‐GABA A receptor positive allosteric modulator attenuates social and cognitive deficits without changing dopamine system hyperactivity in rats exposed to valproic acid in utero},
  journal = {Autism Research},
  year = {2024},
  doi = {10.1002/aur.3178}
}
Kostenlos starten →